---
title: "Viromed Medical AG to Unveil Groundbreaking Cold Plasma Lung Therapy Findings"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/273865951.md"
datetime: "2026-01-27T15:46:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273865951.md)
  - [en](https://longbridge.com/en/news/273865951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273865951.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/273865951.md) | [繁體中文](https://longbridge.com/zh-HK/news/273865951.md)


# Viromed Medical AG to Unveil Groundbreaking Cold Plasma Lung Therapy Findings

Viromed Medical AG will participate in a press conference on February 12, 2026, where Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI) will present scientific findings on a groundbreaking cold plasma therapy for pulmonary application. The event will focus on the therapy’s potential to address severe pulmonary infections, particularly in vulnerable patient groups and intensive care settings. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: corporate\_2266836\_en), on January 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [Geratherm Medical AG (GME.DE)](https://longbridge.com/zh-CN/quote/GME.DE.md)
- [MeVis Medical Solutions AG (M3V.DE)](https://longbridge.com/zh-CN/quote/M3V.DE.md)

## 相关资讯与研究

- [Strong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech Innovation](https://longbridge.com/zh-CN/news/281561864.md)
- [Aedifica investiert 22 Millionen Euro in neues Pflegeheim in Stadtlohn](https://longbridge.com/zh-CN/news/275345742.md)
- [Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call](https://longbridge.com/zh-CN/news/281187029.md)
- [AstraZeneca’s rare disease unit posts positive Phase III data for new hypophosphatasia therapy](https://longbridge.com/zh-CN/news/281133098.md)
- [These retractable studded tires might save our roads, ears, and lungs](https://longbridge.com/zh-CN/news/281011293.md)